Decreased immune response in alexithymic women: A cross-sectional study

Biomedicine and Pharmacotherapy

Volumn 63, Issue 4, 2009, Pages 297-304

  Guilbaud, Olivier ^a,b,c   Curt, Florence ^a   Perrin, Claire ^a   Chaouat, Gérard ^d   Berthoz, Sylvie ^a,b,c   Dugré Le Bigre, Corinne ^a   Wallier, Jenny ^a   Strebler, Martine ^a   Touitou, Catherine ^a   Jeammet, Philippe ^a,b   Corcos, Maurice ^a,b,c  

^a INSTITUT MUTUALISTE MONTSOURIS   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c Universite Paris Sud   (France)

^d HÔPITAL ANTOINE BÉCLÈRE   (France)

Author keywords

Alexithymia; Cytokines; Immunity; Psychoneuroimmunology

Indexed keywords

HYDROCORTISONE; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4;

ADULT; ALEXITHYMIA; ANXIETY; ARTICLE; CD4 LYMPHOCYTE COUNT; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CLINICAL ARTICLE; CROSS-SECTIONAL STUDY; CYTOKINE PRODUCTION; DEPRESSION; FEMALE; HOSPITAL ANXIETY DEPRESSIVE SCALE; HUMAN; HYDROCORTISONE BLOOD LEVEL; IMMUNE DEFICIENCY; LYMPHOCYTE COUNT; MINI NEUROPSYCHIATRIC INTERVIEW; PRIORITY JOURNAL; RATING SCALE; TH1 CELL; TH2 CELL; TORONTO ALEXITHYMIA SCALE;

EID: 67349099407     PISSN: 07533322     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopha.2008.08.007     Document Type: Article

References (56)

1. Sifneos P.E. The prevalence of 'alexithymic' characteristics in psychosomatic patients. Psychother Psychosom 22 (1973) 255-262
2. Nemiah J.C., and Sifneos P.E. Affect and fantasy in patients with psychosomatic disorders. In: Hill O.W. (Ed). Modern trends in psychosomatic medicine (1970), Butterworths, London
3. Todarello O., Taylor G.J., Parker J.D., and Fanelli M. Alexithymia in essential hypertensive and psychiatric outpatients: a comparative study. Psychiatry Res 39 8 (1995) 987-994
4. Dirks J.F., Robinson S.K., and Dirks D.L. Alexithymia and the psychomaintenance of bronchial asthma. Psychother Psychosom 36 (1981) 63-71
5. Numata Y., Ogata Y., Oike Y., Matsumura T., and Shimada K. A psychobehavioral factor, alexithymia, is related to coronary spasm. Jpn Circ J 62 (1998) 409-413
6. Kauhanen J., Kaplan G.A., Julkunen J., and Salonen J.T. The association of alexithymia with all-cause mortality: prospective epidemiologic evidence. Psychosom Med 56 (1994) 149
7. Lumley M.A., Stettner L., and Wehmer F. How are alexithymia and physical illness linked? A review and critique of pathways. J Psychosom Res 41 6 (1996) 505-518
8. Bruni R., Serino F.M., Galluzzo S., Coppolino G., Cacciapaglia F., Vadacca M., et al. Alexithymia and neuroendocrine-immune response in patients with autoimmune diseases. Preliminary results on relationship between alexithymic construct and TNF alpha levels. Ann N Y Acad Sci 1069 (2006) 208-211
9. Carta M.G., Orru W., Hardoy M.C., and Carpiniello B. Alexithymia and early diagnosis of uterine carcinoma: results of a case-control study. Psychother Psychosom 69 6 (2000) 339-340
10. Todarello O., Casamassima A., Daniele S., Marinaccio M., Fanciullo F., Valentino L., et al. Alexithymia, immunity and cervical intraepithelial neoplasia: replication. Psychother Psychosom 66 (1997) 208-213
11. Todarello O., Casamassima A., Marinaccio M., La Pesa M.W., Caradonna L., Valentino L., et al. Alexithymia, immunity and cervical intraepithelial neoplasia: a pilot study. Psychother Psychosom 61 (1994) 199-204
12. Porcelli P., Zaka S., Leoci C., Centoze S., and Taylor G.J. Alexithymia in inflammatory bowel disease: a case-control study. Psychother Psychosom 64 (1995) 49-53
13. Fernandez A., Sriram T.G., Rajkumar S., and Chandrasekar A.N. Alexithymic characteristics in rheumatoid arthritis: a controlled study. Psychother Psychosom 51 1 (1989) 45-50
14. Martin J.B., and Pihl R.O. Influence of alexithymic characteristics on physiological and subjective stress responses in normal individuals. Psychother Psychosom 45 (1986) 66-67
15. Papciak A.S., Feuerstein M., and Spiegel J.A. Stress reactivity in alexithymia: decoupling of physiological and cognitive responses. J Human Stress 11 3 (1985) 135-142
16. Taylor G.J., and Bagby R.M. New trends in alexithymia research. Psychother Psychosom 73 2 (2004) 68-77
17. Guilbaud O., Jeammet P., and Corcos M. Alexithymia, stress and immunity. In: Plotnikoff N. (Ed). Cytokines: stress and immunity. 2nd ed. (2006), Taylor & Francis, Boca Raton, FL 101-109
18. Guilbaud O., Corcos M., Hjalmarsson L., Loas G., and Jeammet P. Is there a psychoneuroimmunological pathway between alexithymia and immunity? Immune and physiological correlates of alexithymia. Biomed Pharmacother 57 7 (2003) 292-295
19. Dewaraja R., Tanigawa T., Araki S., Nakata A., Kawamura N., Ago Y., et al. Decreased cytotoxic lymphocyte counts in alexithymia. Psychother Psychosom 66 2 (1997) 83-86
20. Corcos M., Guilbaud O., Paterniti S., Curt F., Hjalmarsson L., Moussa M., et al. Correlation between serum levels of interleukin-4 and alexithymia scores in healthy female subjects: preliminary findings. Psychoneuroendocrinology 29 5 (2004) 686-691
21. Pedrosa Gil F., Nickel M., Ridout N., Schwarz M.J., Schoechlin C., and Schmidmaier R. Alexithymia and interleukin variations in somatoform disorder. Neuroimmunomodulation 14 5 (2007) 235-242
22. Lindholm T., Lehtinen V., Hyyppa M.T., and Puukka P. Alexithymic features in relation to the dexamethasone suppression test in a Finnish population sample. Am J Psychiatry 147 9 (1990) 1216-1219
23. Heinrichs M., Wagner D., Schoh W., Soravia L.M., Hellhammer D.H., and Ehlert U. Predicting posttraumatic stress symptoms from pretraumatic risk factors: a 2-year prospective follow-up study in firefighters. Am J Psychiatry 162 12 (2005) 2276-2286
24. Lin S., Zhao S.F., and Yan F.H. The influence of alexithymia in stress on secretory IgA and cortisol in saliva. Shanghai Kou Qiang Yi Xue 14 6 (2005) 561-564
25. Finset A., Graugaard P.K., and Holgersen K. Salivary cortisol response after a medical interview: the impact of physician communication behaviour, depressed affect and alexithymia. Patient Educ Couns 60 2 (2006) 115-124
26. McCaslin S.E., Inslight S.A., Neylan T.C., Metzler T.J., Otte C., Lenoci M., et al. Association between alexithymia and neuroendocrine response to psychological stress in Police academy recruits. Ann N Y Acad Sci 1071 (2006) 425-427
27. Koh K.B., and Lee B.K. Reduced lymphocyte proliferation and interleukin-2 production in anxiety disorders. Psychosom Med 60 4 (1998) 479-483
28. Spitzer C., Brandl S., Rose H.J., Nauck M., and Freyberger H.J. Gender-association of alexithymia and norepinephrine/cortisol ratios. A preliminary report. J Psychosom Res 59 (2005) 73-76
29. Henry J.P., Haviland M.G., Cummings M.A., Anderson D.L., Nelson J.C., Mac Murray J.P., et al. Shared neuroendocrine patterns of post-traumatic stress disorder and alexithymia. Psychosom Med 54 4 (1992) 407-415
30. Elenkov I.J., Papanicolaou D.A., Wilder R.L., and Chrousos G.P. Modulatory effects of glucocorticoids and catecholamines on human interleukin-12 and interleukin-10 production: clinical implications. Proc Assoc Am Physicians 108 (1996) 374-381
31. Druet P., Sheela R., and Pelletier L. Th1 and Th2 cells in autoimmunity. Chem Immunol 63 (1996) 138-170
32. Capellino S., Villaggio V., Montagna P., Sulli A., Craviotto C., and Cutolo M. 17beta-Estradiol and testosterone influence the mRNA expression and the time course of inflammatory cytokines in activated human monocytic cell line (THP-1). Reumatismo 57 3 (2005) 193-196
33. Lecrubier Y., Sheehan D.V., Weiller E., Amorim P., Bonora I., Sheehan K.H., et al. The MINI International Neuropsychiatric Interview (MINI). A short diagnostic structured interview: reliability and validity according to the CIDI. Eur Psychiatry 12 (1999) 224-231
34. Bagby R., Parker J.D.A., and Taylor G.J. The Twenty-item Toronto Alexithymia Scale. I. Item selection and cross-validation of the factor structure. II. Convergent, discriminant, and concurrent validity. J Psychosom Res 38 (1994) 33-40
35. Berthoz S., Artiges E., Van De Moortele P.F., Poline J.B., Rouquette S., Consoli S.M., et al. Effect of impaired recognition and expression of emotions on frontocingulate cortices: an fMRI study of men with alexithymia. Am J Psychiatry 159 6 (2002) 961-967
36. Mantani T., Okamoto Y., Shirao N., Okada G., and Yamawaki S. Reduced activation of posterior cingulate cortex during imagery in subjects with high degrees of alexithymia: a functional magnetic resonance imaging study. Biol Psychiatry 57 9 (2005) 982-990
37. Moriguchi Y., Ohnishi T., Lane R.D., Maeda M., Mori T., Nemoto K., et al. Impaired self-awareness and theory of mind: an fMRI study of mentalizing in alexithymia. Neuroimage 32 3 (2006) 1472-1482 Epub 2006 Jun 23
38. Loas G., Otmani O., Fremaux D., Lecercle C., Duflot M., and Delahousse J. External validity, reliability and basic score determination of the Toronto Alexithymia Scales (TAS and TAS-20) in a group of alcoholic patients. Encéphale 22 (1996) 35-40
39. Sheehan D.V., Lecrubier Y., Sheehan K.H., Amorim P., Janavs J., Weiller E., et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 59 Suppl 20 (1998) 22-33;quiz 34-57
40. Zigmond A.S., and Snaith R.P. The Hospital Anxiety And Depression Scale. Acta Psychiatr Scand 67 (1983) 361-370
41. Heatherton T.F., Kozlowski L.T., Frecker R.C., and Fagerstrom K.O. The Fagerstrom test for nicotine dependence: a revision of the Fagerstrom Tolerance Questionnaire. Br J Addict 86 9 (1991) 1119-1127
42. Rein W., Fitzner G., and Heimann H. Evaluation of pathogenic events in psychiatric patients using the anamnestic fiches of the AMDP system. Acta Psychiatr Belg 87 2 (1987) 141-158
43. Kronfol Z., and Remick D.G. Cytokines and the brain: implications for clinical psychiatry. Am J Psychiatry 157 (2000) 683-694
44. Pouliot P., Turmel V., Gélinas E., Laviolette M., and Bissonnette E.Y. Interleukin-4 production by human alveolar macrophages. Clin Exp Allergy 35 6 (2005) 804-810
45. Thorton A.M., and Shevach E.M. CD4+ CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J Exp Med 188 (1998) 287
46. Jonuleit H., and Schmitt E. The regulatory T cell family: distinct subsets and their interrelations. J Immunol 171 12 (2003) 6323-6327
47. Weiner H.L. Induction and mechanism of action of transforming growth factor-beta-secreting Th3 regulatory cells. Immunol Rev 182 (2001) 207-214
48. Nagata T., Yamada H., Iketani T., and Kiriike N. Relationship between plasma concentrations of cytokines, ratio of CD4 and CD8, lymphocyte proliferative responses, and depressive and anxiety state in bulimia nervosa. J Psychosom Res 60 (2006) 99-103
49. Fukunishi I., and Rahe R.H. Alexithymia and coping with stress in healthy persons: alexithymia as a personality trait is associated with low social support and poor responses to stress. Psychol Rep 76 (1995) 1299-1304
50. Cohen E., Klein E., Fried G., Zinder O., and Polack S. Increased emotional distress in daughters of breast cancer patients is associated with decreased natural cytotoxic activity, elevated levels of stress hormones and decreased secretion of Th1 cytokines. Int J Cancer 100 (2002) 347-354
51. Glaser R., Mac Callum R.C., Laskowski B.F., Malarkey W.B., Sheridan J.F., and Kiecolt-glaser J.K. Evidence for a shift in the Th-1 to Th-2 cytokine response associated with chronic stress and aging. J Gerontol A Biol Sci Med Sci 56 (2001) M477-M482
52. Segerstrom S.C., and Miller G.E. Psychological stress and the human immune system: a meta-analytic study of 30 years of inquiry. Psychol Bull 130 4 (2004) 601-630
53. Merlot E., and Neveu P.J. Perturbations biologiques au cours du stress: que mesurer? Comment mesurer?. In: Thurin J.M., and Baumann N. (Eds). Stress, pathologies et immunité (2003) 109-118 Flammarion: Médecine-Sciences
54. Dhabhar F.S., and Mc Ewen B.S. Bi-directional effects of stress on immune function: possible explanations for salubrious as well as harmful effects. In: Ader R. (Ed). Psychoneuroimmunology. 4th ed. vol. 2 (2007), Elsevier Academic Press publications 23-760
55. Van Der Kleij H.P.M., and Bienenstock J. Significance of sensory neuropeptides and the immune response. In: Ader R. (Ed). Psychoneuroimmunology. 4th ed vol. 1 (2007), Elsevier Academic Press publications 97-129
56. In: Cavaillon J.M. (Ed). Les cytokines (1997), Masson, Paris